Fundraising Fox

Vanqua Bio

Chicago, US · Founded 2019 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

RS
Rand SutherlandExecutive
JSJames Sullivan
James SullivaninExecutiveInvestor at OrbiMed

Board

JSJonathan Silverstein
Jonathan SilversteininBoard directorPartner at OrbiMed
BD
Bernard DavitianBoard director
UC
Uya ChuluunbaatarBoard director
MAMona Ashiya
Mona AshiyainBoard directorGeneral Partner at OrbiMed

Investors · 2

Pontifax Venture CapitalHerzeliya · $6.3M – $128M
OrbiMedreported · 2 sourcesNew York · $1M – $75Mvia Mona Ashiya · board

Reported raises · per SEC filings

Form D private placements

$136M disclosed across 3 rounds · 2019–2024

▶$45MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SilversteinDirector
  • Rand SutherlandDirector
  • Bernard DavitianDirector
  • Uya ChuluunbaatarDirector
  • James SullivanExecutive Officer, Director
  • Mona AshiyaDirector
Offering amount
$45M
Amount sold
$45M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedSep 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mona AshiyaDirector
  • Viola MeehanExecutive Officer
  • Bernard DavitianDirector
  • Sara NayeemDirector
  • James SullivanExecutive Officer, Director
  • Jonathan SilversteinDirector
  • Stephen SquintoDirector
Offering amount
$85M
Amount sold
$85M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedOct 2019 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • JONATHAN SILVERSTEINExecutive Officer, Director
  • JAMES SULLIVANExecutive Officer, Director
  • MONA ASHIYADirector
Offering amount
$18M
Amount sold
$6M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Northwestern biotech spinout Vanqua Bio raises more funds | Crain's Chicago Businesschicagobusiness.com · Jul 2024How Vanqua Bio's new funding sets up the Chicago biotech startup for continued success - Chicago Business Journalbizjournals.com · Jul 2024Biotech startup Vanqua Bio secures new funding - Chicago Business Journalbizjournals.com · Jul 2024Vanqua Bio snags $85M series B to vanquish Parkinson's, Gaucher, ALS and Alzheimer's | Fierce Biotechfiercebiotech.com · Sep 2021Vanqua Bio Launches with $85 Million to Target Neurodegenerative Diseases - Global Genesglobalgenes.org · Sep 2021Vanqua Bio Launches with $85 Million Series B Financing and a Mission to Vanquish Neurodegenerative Diseases | Avoro Capital Advisorsavorocapital.com · Sep 2021

Frequently asked questions

Who are Vanqua Bio's investors?
Vanqua Bio's investors include Pontifax Venture Capital, OrbiMed.
How much funding has Vanqua Bio raised?
Vanqua Bio has disclosed $136M raised across 3 rounds.
Where is Vanqua Bio headquartered?
Vanqua Bio is headquartered in Chicago, US.